bims-oxygme Biomed News
on Oxygen metabolism
Issue of 2025–06–08
four papers selected by
Onurkan Karabulut, Berkeley City College



  1. J Physiol. 2025 May 31.
      As part of the CNS, the retina maintains high metabolic activity yet is more tolerant to the adverse effects of low oxygen (hypoxia) than the brain. Tissue hypoxia is a component of ischaemia and has devastating effects on the CNS, including neuronal death. Differences in blood supply, oxygen consumption, and the expression of excitatory receptors and oxygen-binding proteins contribute to regional differences in the sensitivity of retinal neurons to hypoxia. Although highly variable and species-dependent, the mammalian retina has the capacity to withstand the effects of oxygen deprivation through ischaemic preconditioning, where a brief, sublethal stimulus imparts protection against subsequent bouts of hypoxia or ischaemia. Decades of research have demonstrated that hypoxia- and anoxia-tolerant ectotherms are adapted to survive weeks or months in the absence of oxygen without damage to the CNS, nor without the need for a preconditioning stimulus. Recent studies provide evidence that, in the retinas of tolerant animals, such as crucian carp, freshwater turtle and goldfish, prolonged oxygen deprivation elicits a reversible reduction in electroretinogram activity. Moreover, inhibitory interneurons of the outer retina involved in visual processing, called horizontal cells, sense hypoxia via mitochondrial ATP-dependent K+ channels and regulate intracellular Ca2+ homeostasis. An understanding of how these mechanisms may protect the retina from hypoxia has only recently begun to emerge but may involve downregulation of excitatory receptor activity or release of the inhibitory neurotransmitter, GABA, to reduce neuronal activity and reduce the metabolic demands of the retina during oxygen deprivation.
    Keywords:  anoxia; goldfish; ischaemic preconditioning; mKATP; retina; tolerance
    DOI:  https://doi.org/10.1113/JP287741
  2. Mod Rheumatol. 2025 Jun 02. pii: roaf046. [Epub ahead of print]
      Rheumatoid arthritis (RA) is a chronic autoimmune disease with synovitis as the main pathologic change, and acute exacerbation severely affects patients' quality of life, but its specific pathogenesis has not been clarified. The effects of low-pressure hypoxia brought on by high-altitude surroundings and intestinal hypoxia have received comparatively less attention, even though hypoxia is a distinct state in the synovium of RA. In an effort to offer fresh approaches and ideas for treating RA, reducing pain, and enhancing quality of life, this review updates the mechanism of synovial hypoxia on RA in recent years. It also advances the theory that intestinal hypoxia and low-pressure hypoxia in the external environment also aggravate arthritis.
    Keywords:  hypoxia-inducible factors; intestinal hypoxia; plateau hypobaric hypoxia; rheumatoid arthritis; synovial hypoxia
    DOI:  https://doi.org/10.1093/mr/roaf046
  3. Front Physiol. 2025 ;16 1592176
      Once considered passive carriers of oxygen, erythrocytes are now understood to play active roles in regulating oxygen homeostasis and redox balance. This review examines the molecular mechanisms through which red blood cells adapt to hypoxic conditions, including nitric oxide (NO)-driven changes in membrane properties, βCys93-dependent S-nitrosylation, adenosine-induced activation of glycolysis, and the development of hypoxic memory via eENT1 degradation. Enzymes such as RBC eNOS, CYB5R3, and G6PD are essential for maintaining NO availability and redox balance by controlling redox state and NADPH synthesis. In addition to their role in gas transport, erythrocytes contribute to intercellular communication, retain organelle remnants under pathological conditions, and are being explored as platforms for drug delivery. Progress in nanotechnology and gene editing has expanded their clinical applications. These findings present erythrocytes as adaptable, multifunctional cells that connect cellular metabolism, vascular biology, and translational research.
    Keywords:  CYB5R3; RBC eNOS; adenosine; drug delivery systems; erythrocytes; hypoxia; nitric oxide; βCys93
    DOI:  https://doi.org/10.3389/fphys.2025.1592176
  4. Histol Histopathol. 2025 May 20. 18941
       BACKGROUND: Myocardial ischemia-reperfusion injury (MIRI) is a major contributor to myocardial infarction and leads to significant myocardial dysfunction. Mitochondria, crucial for cellular energy production, are particularly susceptible to damage during ischemia/reperfusion (I/R) events. Carbon monoxide-releasing molecule-3 (CORM-3), a water-soluble compound that releases carbon monoxide (CO), has demonstrated multiple protective effects against I/R injury. Mitochondria are recognized as selective targets for CO's protective actions in cells.
    PURPOSE: This study aimed to explore whether CORM-3 mitigates cardiomyocyte injury during hypoxia/reoxygenation (H/R) by regulating the mitochondrial-mediated apoptosis pathway and mitochondrial respiration.
    METHODS: Neonatal rat cardiomyocytes were cultured and randomly assigned into four groups: control group, H/R group (hypoxia for three hours followed by reoxygenation for six hours), CORM-3 group, and inactivated CORM-3 (iCORM-3) group. CORM-3 and iCORM-3 (12.5 µmol/L) were administered at the onset of hypoxia. Mitochondrial ultrastructure was assessed using transmission electron microscopy. The protein levels of caspase-3, caspase-9, mitochondrial cytochrome c, and cytosolic cytochrome c were analyzed via western blot. Mitochondrial membrane potential and intracellular reactive oxygen species (ROS) were measured by flow cytometry. ATP levels were quantified using an ATP Assay Kit, and mitochondrial respiratory chain complex IV activity was determined using a cytochrome oxidase activity colorimetric assay kit.
    RESULTS: CORM-3 effectively reduced myocardial mitochondrial structural damage induced by H/R and downregulated the expression of caspase-3, caspase-9, and cytosolic cytochrome c. Moreover, CORM-3 inhibited cytochrome c release from mitochondria and enhanced mitochondrial membrane potential. Additionally, CORM-3 diminished ROS production and increased the activity of mitochondrial respiratory complex IV in cardiomyocytes. CORM-3 also alleviated the decline in ATP levels following H/R. The protective effects were lost when using inactivated CORM-3 (iCORM-3), suggesting that CO is the active mediator.
    CONCLUSION: The results indicate that CORM-3 effectively alleviates myocardial injury during H/R by inhibiting mitochondria-mediated apoptosis and enhancing mitochondrial respiratory function.
    DOI:  https://doi.org/10.14670/HH-18-941